Navigation Links
Pharmac Blamed Of Depriving People of Lifesaving Drug

Two cardiologists accuse Pharmac of not properly funding the cholesterol lowering drugs to the new Zealanders. They published the report in the New Zealand medical //journal which they point out the shortsighted approach of the agency toward important drugs.

Cardiologists Dr Chris Ellis and Dr Harvey White said that the agency did not allocate funds for the statins for a period of 20 years.

Statins are drugs which help in the reduction of cholesterol levels and prevent heart problems such as heart attacks and strokes.

Pharmac's policies have limited the access of statins to the patients who were in dire need of the drug. This has increased the number of people suffering from heart problems due to inaccessibility of the drug. Hence the cardiologists accuse the agency of patient neglect and public deceit.

The statins are very efficient in lowering the cholesterol levels by about 58%. The initial clinical trails conducted during1986 is a proof for the efficiency of the drug. Despite of its efficiency the drug was not made widely available to patients in New Zealand until 1997. After which only statins which showed no mortality and low beneficial outcomes were funded by the agency.

The report by the cardiologist therefore blames Pharmac for misrepresenting scientific data, ignoring evidence based medicine and restricting access to medicine with the help of bureaucratic hurdles. This has resulted in more harm and premature death to New Zealanders.

National's Associate Health spokeswoman Jackie Blue said that the agency would have to alter its funding policy for the welfare of the people and also to attract more pharmaceutical companies.


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmacies in for a dose of bitter medicine
5. Pharmacia may take 51.5 percent Abbott stake
6. Pharmaceutical companies are targeting patients
7. FDA approves Watson Pharmaceuticals Oxytrol patch
8. Pharmacist’s Role in Medication Error
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology: